Growth Process and Development of the Musculoskeletal System in Young Gymnasts
Launched by UNIVERSITY OF HAIFA · Mar 12, 2024
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the growth and development of the muscles and bones in young female gymnasts. Over the course of three years, the researchers will evaluate the gymnasts' musculoskeletal system twice a year to understand how their bodies change as they train intensively. The goal is to learn more about how gymnastics training affects young athletes, especially during their developmental years.
To participate in this study, young female gymnasts need to train at least four times a week and spend a minimum of 16 hours weekly practicing at a competitive level. They should have been training regularly without significant breaks for pain or injuries. Participants will receive regular assessments during the study, which will help provide valuable insights into their physical development. It’s important to note that gymnasts with current injuries or those missing training for any reason will not be eligible to join the trial.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • training at least 4 times per week,
- • a minimum of 16 hours per week, at a competitive level.
- • The gymnasts exercised fully three months before the beginning of the study
- • have not been absent more than three days from training due to pain, discomfort, or injury.
- Exclusion Criteria:
- • present injury causing pain
- • missing training.
About University Of Haifa
The University of Haifa, a leading institution in Israel renowned for its interdisciplinary research and academic excellence, actively engages in clinical trials to advance scientific knowledge and improve healthcare outcomes. With a strong focus on innovation, the university collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous research that addresses pressing medical challenges. Its commitment to ethical standards and adherence to regulatory requirements underpin the integrity of its clinical trials, fostering an environment that promotes the translation of research findings into practical applications for patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Netanya, , Israel
Patients applied
Trial Officials
Gali Dar
Principal Investigator
University of Haifa
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported